Effectiveness evaluation of telmisartan in patients with hypertension and metabolic syndrome

Z.K. Guseinova, D.Z. Taijanova, Z.B. Tauesheva

Karaganda State Medical University, Republic of Kazakhstan

This article analyzes the impact of antihypertensive preparation from group of angiotensin receptor antagonists (ARA) - «Telmisartan» in the treatment of 40 patients with arterial hypertension and metabolic syndrome.

During the treatment there was a significant reduction in the target blood pressure in76% ofpatients group I at day 6 from the beginning of antihypertensive therapy, resulting in a further correction treatment. Whereas in 95% of patients group II observed a significant hypotensive effect on day 3 of the therapy beginning.

Treatment with ARA - «Telmisartan» led to sustained reduction in blood pressure and improve the lipid profile of blood serum which can prevent the development of atherosclerosis in these patients. Telmisartan, along with a decrease in blood pressure, has a favorable pleiotropic effect and is one of the drugs of choice for the prevention of cardiovascular complications in patients with hypertension and AO.

Keywords: hypertension, metabolic syndrome, angiotensin receptor antagonists, Telmisartan.

Download file:

---